SCHEMBL18927239

SCHEMBL18927239

CC1=NC(c2cc(Br)ccc2C)(C2CCC(C)CC2)NC1=S

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
BACE1 P56817 10/20 0.31
APP P05067 6/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21654362 0.89 BACE1 (0.39) BACE1APPALDH1A1
SCHEMBL18562904 0.87 BACE1 (0.41) BACE1APP
SCHEMBL21654400 0.83 BACE1 (0.32) BACE1APP
SCHEMBL18927279 0.82 BACE1 (0.31) BACE1APP
SCHEMBL945249 0.79 CHRNA1 (0.37) BACE1ALDH1A1
SCHEMBL18926447 0.74 BACE1 (0.43) BACE1APP
SCHEMBL945466 0.74 CHRNA1 (0.36) BACE1
SCHEMBL19567276 0.72 APP (0.38) BACE1APP
SCHEMBL18927263 0.70 BACE1 (0.44) BACE1APP
SCHEMBL945271 0.69 PARP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176172-B1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS ASTRAZENECA AB (SE) 2020-01-29 EP disclosed
EP-3176172-A1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS Astrazeneca AB (SE) 2017-06-07 EP disclosed